GTC Biotherapeutics (fka GTCB)

[jessellivermore]

Most likely the potential partners wanted too big of a slice of the Atryn pie; ie. profits GTCB would need to avoid a recurence of their present problem. The company has a hill composed of time to get over until they can generate their own sustaining revenues. The time is not really that long. Considering the likely options this dilution is probably their best one, certainly IMHO a better one than giving away vital future Atryn profits which would result in a huge very long term problem.